Home > Compound List > Product Information
N-Boc-2-piperidineethanol_Molecular_structure_CAS_118811-03-3)
Click picture or here to close

N-Boc-2-piperidineethanol

Catalog No. 668265 Name Sigma Aldrich
CAS Number 118811-03-3 Website http://www.sigmaaldrich.com
M. F. C12H23NO3 Telephone 1-800-521-8956
M. W. 229.31592 Fax
Purity 97% Email
Storage Chembase ID: 118287

SYNONYMS

Title
N-叔丁氧羰基-2-哌啶-2-基乙醇
IUPAC name
tert-butyl 2-(2-hydroxyethyl)piperidine-1-carboxylate
IUPAC Traditional name
tert-butyl 2-(2-hydroxyethyl)piperidine-1-carboxylate
Synonyms
N-Boc-2-(2-hydroxymethyl)piperidine
1-tert-Butoxycarbonyl-2-piperidineethanol
N-Boc-2-(2-羟甲基)哌啶
2-(2-羟乙基)哌啶-1-羧酸叔丁酯
2-(2-Hydroxyethyl)piperidine-1-carboxylic acid tert-butyl ester

DATABASE IDS

PubChem SID 24884972
MDL Number MFCD03701252
CAS Number 118811-03-3

PROPERTIES

Empirical Formula (Hill Notation) C12H23NO3
Purity 97%
Boiling Point 100-110 °C/0.3 mmHg
Density 1.032 g/mL at 25 °C
Flash Point >110 °C
Flash Point >230 °F
Refractive Index n20/D 1.472
GHS Pictograms GHS06
GHS Pictograms GHS09
GHS Signal Word Danger
GHS Hazard statements H301-H319-H400
European Hazard Symbols Toxic Toxic (T)
MSDS Link Download
Personal Protective Equipment Eyeshields, Faceshields, full-face respirator (US), Gloves, multi-purpose combination respirator cartridge (US), type ABEK (EN14387) respirator filter
GHS Precautionary statements P273-P301 + P310-P305 + P351 + P338
RID/ADR UN 2810 6.1/PG 3
Risk Statements 25
Safety Statements 45
Hazard Class 6.1
UN Number 2810
Packing Group 3
German water hazard class 3

DETAILS

Description (English)
Packaging
5 g in glass bottle
Application
Reactant for synthesis of:
• Vasopressin1b receptor antagonists1
• CXCR4 antagonists as anti-HIV agents2
• Coumarin-based inhibitors of inducible nitric oxide synthase3
• Selective thrombin inhibitors4Reactant for:
• N-directed hydroboration for synthesis of amino alcohols5
• Enantioselective synthesis of sedamine and allosedamine6
Description (简体中文)
包装
5 g in glass bottle
Application
Reactant for synthesis of:
• Vasopressin1b receptor antagonists1
• CXCR4 antagonists as anti-HIV agents2
• Coumarin-based inhibitors of inducible nitric oxide synthase3
• Selective thrombin inhibitors4Reactant for:
• N-directed hydroboration for synthesis of amino alcohols5
• Enantioselective synthesis of sedamine and allosedamine6

REFERENCES